Eliem

According to a new filing with the U.S. Securities and Exchange Commission, Emily Pimblett, chief accounting officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), recently sold a portion of her company’s stock. The transactions, which took…

Valerie Morissette, Executive Vice President of Research and Development and Chief Scientific Officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), sold a significant number of shares of the company. On July 3, 2024, Morissette disposed of…